During the past decade, Ocean Blue Medical Research Center Inc. conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 15 clinical trials were completed, i.e. on average, 88.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 10 clinical trials were completed. i.e. 142.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ocean Blue Medical Research Center Inc." #1 sponsor was "Pfizer" with 4 trials, followed by "Arrowhead Pharmaceuticals" with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored, "Bayer" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ocean Blue Medical Research Center Inc." #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Allergan Sales, LLC" with 1 trials as a collaborator, "Camurus AB" with 1 trials as a collaborator, "CoLucid Pharmaceuticals" with 1 trials as a collaborator and "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Ocean Blue Medical Research Center Inc." are "Type 2 Diabetes" (3 trials), "Cardiovascular Disease" (2 trials), "Nonalcoholic Steatohepatitis" (2 trials), "COVID-19" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Ocean Blue Medical Research Center Inc." in a lesser frequency.

Most popular intervention types in "Ocean Blue Medical Research Center Inc." are "Drug" (21 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "ARO-APOC3" (3 trials), "Dapagliflozin" (2 trials), "BI 685509" (1 trials) and "BI 767551 inhaled" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ocean Blue Medical Research Center Inc." are 21 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ocean Blue Medical Research Center Inc.". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 14 completed trials in Ocean Blue Medical Research Center Inc., 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ocean Blue Medical Research Center Inc., 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".